![](/img/cover-not-exists.png)
Aerosol liposomal interleukin-2 (alL-2) combined with interferon alpha-2h/Ribavirin (IFN/R) as a novel approach in chronic hepatitis C (HCV) patients who failed previous IFN/R treatment: A preliminary report
Nizar N. Zein, Rosa M. Ten, John B. Gross Jr., Rollan C. Dickson, John J. Poterucha, Laurie A. Czaplewski, Claudia O. Zein, Peter M. AndersonVolume:
120
Year:
2001
Language:
english
DOI:
10.1016/s0016-5085(08)80380-0
File:
PDF, 193 KB
english, 2001